A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Under Fed Conditions

NCT04718805 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Darunavir
DRUG: Cobicistat
DRUG: Darunavir/Cobicistat FDC

Sponsor

Janssen Research & Development, LLC